LTFS
RKDA icon

Ladenburg Thalmann Financial Services’s Arcadia Biosciences RKDA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Hold
3
– – ﹤0.01% 5224
2019
Q3 		$0 Buy
+3
New +$575 ﹤0.01% 5416

Other funds holding RKDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ladenburg Thalmann Financial Services's RKDA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Arcadia Biosciences (RKDA) position steady in Q4 2019 at 3 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5224.

Ladenburg Thalmann Financial Services first reported a position in RKDA in Q3 2019 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold RKDA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 3 shares of Arcadia Biosciences worth $1K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Arcadia Biosciences share count unchanged in Q4 2019.
  • Arcadia Biosciences made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5224 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Arcadia Biosciences in Q3 2019 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.